Showing 1-5 of 84 big data:
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

June 24, 2024 Pharma’s Almanac Read the full article >> Rich Gliklich, M.D., Chief Executive Officer and founder, OM1 One impactful way will be through platforms that enable data and study automation. In recent remarks, FDA Commissioner Dr. Robert Califf argued that there is tremendous opportunity to simplify and digitize data collection to create more pragmatic[…]

OM1, a Pioneer in Patient Registries, Launches Its Registries Center of Excellence

With a commitment to advancing innovation in patient registries from inception through implementation, the Registries CoE represents a pivotal step toward addressing critical gaps in clinical research June 13, 2024 09:00 AM Eastern Daylight Time Business Wire Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leader in delivering first-in-class RWE technological advancements and AI-powered[…]

Joseph Zabinski, PhD, MEM: Navigating the Future of AI in Skin Cancer Detection

June 3, 2024 Dermatology Times Read the full article >> May recently concluded Melanoma and Skin Cancer Awareness Month, however, the importance of sun protection and early detection doesn’t end with May. Artificial intelligence (AI) continues to be a conversation in dermatology, especially concerning skin cancer detection. To better understand how certain AI platforms can[…]

Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes

At ISPOR Annual 2024, Jessica Probst, MPH presented in the AI in HEOR poster tour on Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes. This poster was also a Top 5% Finalist for the ISPOR 2024 Research Presentation Awards. View the full poster >>

1 2 3 17